Kim, Jocelyn T. http://orcid.org/0000-0001-7040-5773
Zhang, Tian-Hao
Carmona, Camille http://orcid.org/0000-0001-7725-391X
Lee, Bryanna
Seet, Christopher S. http://orcid.org/0000-0002-4821-1400
Kostelny, Matthew
Shah, Nisarg
Chen, Hongying
Farrell, Kylie
Soliman, Mohamed S. A. http://orcid.org/0000-0003-1892-4917
Dimapasoc, Melanie http://orcid.org/0000-0003-0328-315X
Sinani, Michelle
Blanco, Kenia Yazmin Reyna
Bojorquez, David http://orcid.org/0000-0002-4044-6635
Jiang, Hong
Shi, Yuan http://orcid.org/0000-0002-9993-0448
Du, Yushen
Komarova, Natalia L.
Wodarz, Dominik http://orcid.org/0000-0002-8017-3707
Wender, Paul A.
Marsden, Matthew D.
Sun, Ren
Zack, Jerome A. http://orcid.org/0000-0001-5486-8495
Funding for this research was provided by:
amfAR, The Foundation for AIDS Research (110057-69-RGRL)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (UL1TR001881)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (AI131294, AI124743, AI145038)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases
National Science Foundation (DMS1662146/1662096)
UCLA Center for AIDS Research (AI28697). The UCLA AIDS Institute and the McCarthy Family Foundation and UCLA Department of Medicine
Article History
Received: 14 October 2021
Accepted: 3 December 2021
First Online: 10 January 2022
Competing interests
: Stanford University has filed patent applications on SUW133 and related technology, which has been licensed by Neurotrope BioScience (Synaptogenix, Inc.) and Bryologyx Inc. P.A.W. is an adviser to both companies and a cofounder of the latter. J.A.Z. is a cofounder of CDR3 Therapeutics and is on the SAB of Bryologyx. The remaining authors declare no competing interests.